SUMMIT Trial Study Group
Week six got a bit harder

What a weight loss clinic actually sells in 2026 (hint: it's not just prescriptions) The real offer: assessment + plan + monitoring + support Regular coaching sessions with trained specialists Nutrition guidance and meal planning Behavioral therapy addressing emotional eating Community support through group sessions or digital communities Education about environmentally responsible health habits Why "GLP-1-only clinics" struggle (trust, retention, operations) The clinic model that scales: standardized pathways with personalization Choose your clinic model: in-person, telehealth, or hybrid When telehealth is the best fit (and when it's not) Busy professionals and caregivers who can't make it to regular in-person visits due to packed schedules People in rural areas who don't have easy access to obesity medicine or bariatric care Medically stable patients with conditions like prediabetes, mild sleep apnea, or early hypertension Tech-savvy people who are comfortable with video calls, home weight tracking, and virtual appointments Hybrid workflows: labs + visits + follow-ups without chaos First in-person visit: full labs, vitals, body composition analysis Virtual follow-ups: medication changes, nutrition coaching, behavioral support Regular clinic visits: progress checks, new measurements, addressing concerns Service area, availability, and patient expectations Appointments that fit their schedule, including after work Quick access to appointments and follow-ups Private, comfy spaces to talk about personal issues Easy ways to reach their care team between visits Regular check-ins to stay on track Define your niche and positioning (so you're not competing on vibes) Pick a patient segment: weight loss, metabolic health, post-partum, peri-menopause, men's health, etc

HG007690, HL119145, GM107618 and American Heart Association grant D700382 to J.L
Diabetes is associated with an increased risk of developing dementia and neurodegenerative diseases, which is inversely related to the degree of glucose tolerance and directly to the disease duration [16]
The authors propose a staged treatment plan that takes into consideration the timing of the treatment ( Table 1 )